SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • Beauvais DM, Burbach BJ, Rapraeger AC. 2004. The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J Cell Biol 167: 171181.
  • Belkin AM, Akimov SS, Zaritskaya LS, Ratnikov BI, Deryugina EI, Strongin AY. 2001. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 276: 1841518422.
  • Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737744.
  • Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM. 2001. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Cancer Res 61: 36103618.
  • Brinckerhoff CE, Matrisian LM. 2002. Matrix metalloproteinases: A tale of a frog that became a prince. Nat Rev Mol Cell Biol 3: 207214.
  • Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA. 1998. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 92: 391400.
  • Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van WS, Crabbe T, Clements J, d'Ortho MP, Murphy G. 1998. The TIMP2 membrane type 1 metalloproteinase “Receptor” regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 273: 871880.
  • Cao J, Sato H, Takino T, Seiki M. 1995. The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270: 801805.
  • Cao J, Kozarekar P, Pavlaki M, Chiarelli C, Bahou WF, Zucker S. 2004. Distinct roles for the catalytic and hemopexin domains of membrane type 1-matrix metalloproteinase in substrate degradation and cell migration. J Biol Chem 279: 1412914139.
  • Chun TH, Sabeh F, Ota I, Murphy H, McDonagh KT, Holmbeck K, Birkedal-Hansen H, Allen ED, Weiss SJ. 2004. MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix. J Cell Biol 167: 757767.
  • d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. 1997. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250: 751757.
  • Deryugina EI, Ratnikov BI, Postnova TI, Rozanov DV, Strongin AY. 2002a. Processing of integrin alpha v subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem 277: 97499756.
  • Deryugina EI, Soroceanu L, Strongin AY. 2002b. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res 62: 580588.
  • Ellerbroek SM, Wu YI, Overall CM, Stack MS. 2001. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J Biol Chem 276: 2483324842.
  • Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, Furukawa M, Sato H. 2003. Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 278: 4076440770.
  • Galvez BG, Matias-Roman S, Yanez-Mo M, Vicente-Manzanares M, Sanchez-Madrid F, Arroyo AG. 2004. Caveolae are a novel pathway for membrane-type 1 matrix metalloproteinase traffic in human endothelial cells. Mol Biol Cell 15: 678687.
  • Gingras D, Bousquet-Gagnon N, Langlois S, Lachambre MP, Annabi B, Beliveau R. 2001. Activation of the extracellular signal-regulated protein kinase (ERK) cascade by membrane-type-1 matrix metalloproteinase (MT1-MMP). FEBS Lett 507: 231236.
  • Harayama T, Ohuchi E, Aoki T, Sato H, Seiki M, Okada Y. 1999. Shedding of membrane type 1 matrix metalloproteinase in a human breast carcinoma cell line. Jpn J Cancer Res 90: 942950.
  • Hiraoka N, Allen E, Apel IJ, Gyetko MR, Weiss SJ. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95: 365377.
  • Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99: 8192.
  • Holmbeck K, Bianco P, Yamada S, Birkedal-Hansen H. 2004. MT1-MMP: A tethered collagenase. J Cell Physiol 200: 1119.
  • Holmbeck K, Bianco P, Pidoux I, Inoue S, Billinghurst RC, Wu W, Chrysovergis K, Yamada S, Birkedal-Hansen H, Poole AR. 2005. The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci 118: 147156.
  • Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 149: 13091323.
  • Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. 2003. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114: 3345.
  • Itoh Y, Nagase H. 2002. Matrix metalloproteinases in cancer. Essays Biochem 38: 2136.
  • Itoh Y, Seiki M. 2004. MT1-MMP: An enzyme with multidimensional regulation. TiBS 29: 285289.
  • Itoh Y, Kajita M, Kinoh H, Mori H, Okada A, Seiki M. 1999. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J Biol Chem 274: 3426034266.
  • Itoh Y, Takamura A, Ito N, Maru Y, Sato H, Suenaga N, Aoki T, Seiki M. 2001. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion. EMBO J 20: 47824793.
  • Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, Pei D. 2001. Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 98: 1369313698.
  • Kajita M, Itoh Y, Chiba T, Mori H, Okada A, Kinoh H, Seiki M. 2001. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 153: 893904.
  • Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, Seiki M. 1998. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 273: 1609816103.
  • Knäuper V, Will H, López-Otín C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G. 1996. Cellular mechanisms for human procollagenase 3 (mmp 13) activation: Evidence that mt1 mmp (mmp 14) and gelatinase a (mmp 2) are able to generate active enzyme. J Biol Chem 271: 1712417131.
  • Kojima S, Itoh Y, Matsumoto S, Masuho Y, Seiki M. 2000. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett 480: 142146.
  • Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V. 2000. Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148: 615624.
  • Koshikawa N, Minegishi T, Sharabi A, Quaranta V, Seiki M. 2005. Membrane-type matrix metalloproteinase-1 (MT1-MMP) is a processing enzyme for human laminin gamma 2 chain. J Biol Chem 280: 8893.
  • Lafleur MA, Handsley MM, Knauper V, Murphy G, Edwards DR. 2002. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J Cell Sci 115: 34273438.
  • Lehti K, Lohi J, Valtanen H, Keski-Oja J. 1998. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 334: 345353.
  • Lehti K, Lohi J, Juntunen MM, Pei D, Keski-Oja J. 2002. Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase. J Biol Chem 277: 84408448.
  • Li Y, Aoki T, Mori Y, Ahmad M, Miyamori H, Takino T, Sato H. 2004. Cleavage of lumican by membrane-type matrix metalloproteinase-1 abrogates this proteoglycan-mediated suppression of tumor cell colony formation in soft agar. Cancer Res 64: 70587064.
  • Mazzone M, Baldassarre M, Beznoussenko G, Giacchetti G, Cao J, Zucker S, Luini A, Buccione R. 2004. Intracellular processing and activation of membrane type 1 matrix metalloprotease depends on its partitioning into lipid domains. J Cell Sci 117: 62756287.
  • Mori H, Tomari T, Koshikawa N, Kajita M, Itoh Y, Sato H, Tojo H, Yana I, Seiki M. 2002. CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain. EMBO J 21: 39493959.
  • Murphy G, Gavrilovic J. 1999. Proteolysis and cell migration: Creating a path. Curr Opin Cell Biol 11: 614621.
  • Nagase H. 1997. Activation mechanisms of matrix metalloproteinases. Biol Chem 378: 151160.
  • Nagase H, Woessner JF, Jr. 1999. Matrix metalloproteinases. J Biol Chem 274: 2149121494.
  • Nakada M, Yamada A, Takino T, Miyamori H, Takahashi T, Yamashita J, Sato H. 2001. Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res 61: 88968902.
  • Naot D, Sionov RV, Ish-Shalom D. 1997. CD44: Structure, function, and association with the malignant process. Adv Cancer Res 71: 241319.
  • Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. 2001. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107: 789800.
  • Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. 1997. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272: 24462451.
  • Osenkowski P, Toth M, Fridman R. 2004. Processing, shedding, and endocytosis of membrane type 1-matrix metalloproteinase (MT1-MMP). J Cell Physiol 200: 210.
  • Remacle A, Murphy G, Roghi C. 2003. Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface. J Cell Sci 116: 39053916.
  • Rozanov DV, Hahn-Dantona E, Strickland DK, Strongin AY. 2004. The low density lipoprotein receptor-related protein LRP is regulated by membrane type-1 matrix metalloproteinase (MT1-MMP) proteolysis in malignant cells. J Biol Chem 279: 42604268.
  • Sabeh F, Ota I, Holmbeck K, Birkedal-Hansen H, Soloway P, Balbin M, Lopez-Otin C, Shapiro S, Inada M, Krane S, Allen E, Chung D, Weiss SJ. 2004. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 167: 769781.
  • Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 6165.
  • Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. 1996. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett 393: 101104.
  • Sato T, del Carmen Ovejero M, Hou P, Heegaard AM, Kumegawa M, Foged NT, Delaisse JM. 1997. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci 110: 589596.
  • Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, Quaranta V. 2003. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 161: 197209.
  • Seiki M. 1999. Membrane-type matrix metalloproteinases. Apmis 107: 137143.
  • Seiki M. 2002. The cell surface: The stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol 14: 624632.
  • Seiki M. 2003. Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion. Cancer Lett 194: 111.
  • Silletti S, Kessler T, Goldberg J, Boger DL, Cheresh DA. 2001. Disruption of matrix metalloproteinase 2 binding to integrin αvβ3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci USA 98: 119124.
  • Sounni NE, Devy L, Hajitou A, Frankenne F, Munaut C, Gilles C, Deroanne C, Thompson EW, Foidart JM, Noel A. 2002. MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression. FASEB J 16: 555564.
  • Sounni NE, Roghi C, Chabottaux V, Janssen M, Munaut C, Maquoi E, Galvez BG, Gilles C, Frankenne F, Murphy G, Foidart JM, Noel A. 2004. Up-regulation of vascular endothelial growth factor-A by active membrane-type 1 matrix metalloproteinase through activation of Src-tyrosine kinases. J Biol Chem 279: 1356413574.
  • Stanton H, Gavrilovic J, Atkinson SJ, d'Ortho MP, Yamada KM, Zardi L, Murphy G. 1998. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J Cell Sci 111: 27892798.
  • Sternlicht MD, Werb Z. 2001. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17: 463516.
  • Stetler-Stevenson WG, Aznavoorian S, Liotta LA. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541573.
  • Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 53315338.
  • Suenaga N, Mori H, Itoh Y, Seiki M. 2005. CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 24: 859868.
  • Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M. 1998. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95: 1322113226.
  • Takino T, Miyamori H, Kawaguchi N, Uekita T, Seiki M, Sato H. 2003. Tetraspanin CD63 promotes targeting and lysosomal proteolysis of membrane-type 1 matrix metalloproteinase. Biochem Biophys Res Commun 304: 160166.
  • Takino T, Miyamori H, Watanabe Y, Yoshioka K, Seiki M, Sato H. 2004. Membrane type 1 matrix metalloproteinase regulates collagen-dependent mitogen-activated protein/extracellular signal-related kinase activation and cell migration. Cancer Res 64: 10441049.
  • Toth M, Hernandez-Barrantes S, Osenkowski P, Bernardo MM, Gervasi DC, Shimura Y, Meroueh O, Kotra LP, Galvez BG, Arroyo AG, Mobashery S, Fridman R. 2002. Complex pattern of membrane type 1 matrix metalloproteinase shedding. Regulation by autocatalytic cells surface inactivation of active enzyme. J Biol Chem 277: 2634026350.
  • Toth M, Osenkowski P, Hesek D, Brown S, Meroueh S, Sakr W, Mobashery S, Fridman R. 2004. Cleavage at the stem region releases an active ectodomain of the membrane type 1-matrix metalloproteinase. Biochem J 387: 497506.
  • Tsunezuka Y, Kinoh H, Takino T, Watanabe Y, Okada Y, Shinagawa A, Sato H, Seiki M. 1996. Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Res 56: 56785683.
  • Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB, Bowden GT. 2003. Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res 63: 22922299.
  • Ueda J, Kajita M, Suenaga N, Fujii K, Seiki M. 2003. Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: Importance of MT1-MMP as a therapeutic target for invasive tumors. Oncogene 22: 87168722.
  • Uekita T, Itoh Y, Yana I, Ohno H, Seiki M. 2001. Cytoplasmic tail-dependent internalization of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity. J Cell Biol 155: 13451356.
  • Uekita T, Gotoh I, Kinoshita T, Itoh Y, Sato H, Shiomi T, Okada Y, Seiki M. 2004. Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein-1 is a new member of the Cupin superfamily. A possible multifunctional protein acting as an invasion suppressor down-regulated in tumors. J Biol Chem 279: 1273412743.
  • Varma R, Mayor S. 1998. GPI-anchored proteins are organized in submicron domains at the cell surface. Nature 394: 798801.
  • Veitch DP, Nokelainen P, McGowan KA, Nguyen TT, Nguyen NE, Stephenson R, Pappano WN, Keene DR, Spong SM, Greenspan DS, Findell PR, Marinkovich MP. 2003. Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J Biol Chem 278: 1566115668.
  • Visse R, Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92: 827839.
  • Wang Z, Juttermann R, Soloway PD. 2000. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275: 2641126415.
  • Wang P, Nie J, Pei D. 2004a. The hemopexin domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) Is not required for its activation of proMMP2 on cell surface but is essential for MT1-MMP-mediated invasion in three-dimensional type I collagen. J Biol Chem 279: 5114851155.
  • Wang P, Wang X, Pei D. 2004b. Mint-3 regulates the retrieval of the internalized membrane-type matrix metalloproteinase, MT5-MMP, to the plasma membrane by binding to its carboxyl end motif EWV. J Biol Chem 279: 2046120470.
  • Wang X, Ma D, Keski-Oja J, Pei D. 2004c. Co-recycling of MT1-MMP and MT3-MMP through the trans-Golgi network. Identification of DKV582 as a recycling signal. J Biol Chem 279: 93319336.
  • Werb Z. 1997. ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91: 439442.
  • Will H, Atkinson SJ, Butler GS, Smith B, Murphy G. 1996. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271: 1711917123.
  • Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P. 2003. Compensation mechanism in tumor cell migration: Mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160: 267277.
  • Wu YI, Munshi HG, Sen R, Snipas SJ, Salvesen GS, Fridman R, Stack MS. 2004. Glycosylation broadens the substrate profile of membrane type 1 matrix metalloproteinase. J Biol Chem 279: 82788289.
  • Yana I, Weiss SJ. 2000. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11: 23872401.
  • Yu Q, Stamenkovic I. 1999. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 13: 3548.
  • Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K. 2000. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97: 40524057.
  • Zucker S, Pei D, Cao J, López-Otín C. 2003. Membrane type-matrix metalloproteinases (MT-MMP). Curr Top Dev Biol 54: 174.